冠狀動脈鈣化被認為是缺血性心臟病及死亡的危險因子。Mönckeberg型動脈粥狀硬化是一種血管鈣化,現在有力的證據顯示這可能是維生素K缺乏所導致;維生素K-2,特別是來自於食物,像是乳酪的MK-4型式則具保護作用。維生素K拮抗劑-warfarin阻斷肝及周邊的維生素K循環,造成次發性維生素K缺乏,而引發脈管結構、骨頭、腎臟、腦及其它組織系統的副作用(例如發炎、免疫功能及腫瘤)。個體對維生素K缺乏的易感性及warfarin敏感性,部分可以基因多型性、表觀遺傳學、飲食及藥物治療所解釋。本文描述一位有心房顫動的男性病患,在過去十年一直以warfarin治療,被發現有廣泛性的冠狀動脈鈣化,因而帶出這個目前臨床管理的難題。最後提出一套推斷的建議。
Coronary artery calcification is a recognised risk factor for ischaemic heart disease and mortality. Evidence is now strong that Mönckeberg's arteriosclerosis, a form of vascular calcification, can be attributable to vitamin K deficiency, but that vitamin K-2, especially the MK-4 form from foods like cheese can be protective. Warfarin blocks the recycling of hepatic and peripheral vitamin K leading to secondary vitamin K deficiency with adverse effects on vasculature, bone, kidneys, brain and other tissues and systems (inflammatory, immune function and neoplasia at least). There is individual susceptibility to vitamin K deficiency and warfarin sensitivity, partly explicable in terms of genetic polymorphisms, epigenetics, diet and pharmacotherapy. The emergence of extensive coronary calcification in a man with atrial fibrillation treated for a decade with warfarin is described by way of illustration and to raise the present clinical management conundrums. Finally, a putative set of recommendations is provided.